- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04043910
Functional Near Infra-Red Spectroscopic Study of Central Auditory System Cortical Functional Reorganization (SUN)
Functional Near Infra-Red Spectroscopic Study of Central Auditory System Cortical Functional Reorganization in Unilateral Deaf Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Binaural hearing allows strengthening of speech intelligibility in noise and sound localization. It is well known that single-sided (SSD) and bilateral asymmetric deafness lead to socio-behavioral consequences and, in children, inducing impairments in learning acquisitions.
In adults, SSD is associated with a reduction of inter-hemispheric functional asymmetry of auditory cortex on functional Magnetic Resonance Imaging. Moreover, in children with bilateral profound deafness who got one cochlear implant (inducing a form of asymmetric hearing), these clinical and functional anomalies cannot be overcome in case of a late (>1,5year) secondary implantation. This shows that once the loss of asymmetry is installed, it is difficult to recover from it.
No data about SSD in children and its cortical representation exists. In this study, the investigators hypothesized that SSD modifies the auditory cortical activation profile, linked with a deterioration of the binaural auditory skills, the global development and the quality of life If this hypothesis is confirmed, systematic and individualized rehabilitation will be needed to reduce patient's handicap and to prevent long term consequences.
The investigators will then measure the auditory cortical activity using fNIRS in 5 to 16 year-old SSD and NH children. The fNIRS system will use a sensor-bearing cap, measuring cortical activity through the scalp. Binaural hearing (speech in noise and localisation), speech assessments (global and speech development), and QoL will also be measured.
Children will undergo 2 sessions of 1 to 2 hours tests, each spaced up to 3 months apart. As they are children regularly seen in our ear-nose-throat department, a once-a-year follow-up will be proposed, on the child and his family convenience. As it is a non-interventional study, no follow-up would be needed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Toulouse, France, 31059
- Hopital Pierre Paul Riquet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria :
For both groups:
- 5 to 16 year-old children,
- Absence of pregnancy
- Affiliation to Social Security, and children and their parents signed consents will be necessary.
- Participation agreement of the protocol and signature of the consent form by the person having parental authority and the child
For Single-sided Deafness subjects:
- shall present with moderate to profound unilateral hearing loss, with a hearing loss of 40 decibel(minimal thresholds), assessed on tonal, vocal audiometry, Auditory Brainstem Responses,
For Normal hearing subjects:
- shall have normal hearing, demonstrated by air thresholds below 20 decibel by an audiometric control before inclusion , matched in gender and age to children in the experimental group
Exclusion Criteria:
For both groups:
- Antecedents of Psycho-neurological diseases,
- Other sensorineural or motor deficiency,
- Familial bilingualism,
- Medications affecting vigilance.
- pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single-sided deaf group
30 children will be included in this group
|
The auditory cortical imaging will be performed by fNIRS measures.
This non-invasive functional imaging technique relies on the use of a sensor-bearing cap, measuring cortical activity through scalp, during auditory stimulation.
As head movement does not alter measurement that much, fNIRS is well adapted to children.
Speech intelligibility will be evaluated with French sentences comprehension in noise, from the Common Test or Adaptive Auditive Speech Test before 6 years, from the Common Test or Hearing in Noise Test for Children (Hint-C) from 7 to 11 years, and from the Hint-C or Marginal Benefit of Acoustic Amplification after 11 years, both with a Signal over Noise Ratio of +10 decibel at 65 decibel
Sound localisation will be evaluated with a left-right discrimination test before 7 years and a 12 loudspeakers sound localisation test after 7 years.
Speech assessments will be performed by dedicated speech therapists, with child age specific tests, and 2 global speech scores: the Category of Auditory Performances scale - second edition, and the Speech Intelligibility Rating scale.
Quality of Life (QoL) evaluation will be based on the generic QoL scale, and the Speech Spatial and Qualities of hearing (SSQ) deafness specific scale.
Each scale exists in age specific modalities.
|
Active Comparator: Normal hearing group
30 children will be included in this group
|
The auditory cortical imaging will be performed by fNIRS measures.
This non-invasive functional imaging technique relies on the use of a sensor-bearing cap, measuring cortical activity through scalp, during auditory stimulation.
As head movement does not alter measurement that much, fNIRS is well adapted to children.
Speech intelligibility will be evaluated with French sentences comprehension in noise, from the Common Test or Adaptive Auditive Speech Test before 6 years, from the Common Test or Hearing in Noise Test for Children (Hint-C) from 7 to 11 years, and from the Hint-C or Marginal Benefit of Acoustic Amplification after 11 years, both with a Signal over Noise Ratio of +10 decibel at 65 decibel
Sound localisation will be evaluated with a left-right discrimination test before 7 years and a 12 loudspeakers sound localisation test after 7 years.
Speech assessments will be performed by dedicated speech therapists, with child age specific tests, and 2 global speech scores: the Category of Auditory Performances scale - second edition, and the Speech Intelligibility Rating scale.
Quality of Life (QoL) evaluation will be based on the generic QoL scale, and the Speech Spatial and Qualities of hearing (SSQ) deafness specific scale.
Each scale exists in age specific modalities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxyhemoglobin rates
Time Frame: 3 months
|
Oxyhemoglobin (O2Hb) rates measured on the auditory cortex of each cerebral hemisphere during an auditory stimulus.
|
3 months
|
Deoxyhemoglobin rates
Time Frame: 3 months
|
Deoxyhemoglobin (HHb) rates measured on the auditory cortex of each cerebral hemisphere during an auditory stimulus.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Binaural audiological performances
Time Frame: 3 months
|
Speech in noise intelligibility and spatial sound localization ability
|
3 months
|
Speech assessment
Time Frame: 3 months
|
Hearing perception thanks to Category of Auditory Performances - Nottingham Early Assessment Package 4 and speech intelligibility thanks to the Speech Intelligibility Rating - Nottingham Early Assessment Package 5
|
3 months
|
Quality of life scores
Time Frame: 3 months
|
Quality of Life (QoL) evaluation will be based on the KindLR generic QoL scale.
This scale exists in age specific modalities.
|
3 months
|
Quality of life scores
Time Frame: 3 months
|
Quality of Life (QoL) evaluation will be based on scale, and the Speech Spatial and Qualities of hearing (SSQ) deafness specific scale.
This scale exists in age specific modalities.
|
3 months
|
Activity levels
Time Frame: 3 months
|
fNIRS measured cortical of activity levels
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marie-Noëlle CAMELS, Toulouse University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC31/17/0321
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Unilateral
-
Manohar BanceDalhousie UniversityCompletedUnilateral Hearing Loss | Unilateral Deafness
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
Sonitus Medical IncCompletedHearing Loss | Unilateral Hearing Loss | Total Unilateral DeafnessUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Cochlear Bone Anchored SolutionsCompletedSingle Sided Sensorineural Deafness | Mixed Hearing Loss, UnilateralDenmark, Spain, United Kingdom, Belgium
-
University Hospital, GhentWithdrawnConductive Hearing Loss | Unilateral Deafness | Mixed Hearing LossBelgium
-
Massachusetts Eye and Ear InfirmaryCompletedUnilateral Hearing LossUnited States
-
University Hospital, ToulouseCompletedUnilateral Hearing LossFrance
-
Sonitus Medical IncCompletedUnilateral Hearing LossUnited States
-
University of South FloridaOticon MedicalRecruitingHearing Loss, Conductive | Hearing Loss, Mixed | Deafness, UnilateralUnited States
Clinical Trials on fNIRS
-
Dr Georg KranzRecruiting
-
Icahn School of Medicine at Mount SinaiRecruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
KernelRecruitingMild Cognitive ImpairmentUnited States
-
Centre Hospitalier Régional d'OrléansCompleted
-
University Hospital TuebingenJapan society for the promotion of science; Nakatani foundation and Japan foundation...Completed
-
National Taiwan University HospitalNational Science Council, TaiwanRecruitingAnxiety DisordersTaiwan
-
Florida State UniversityRecruiting
-
The University of Texas Health Science Center,...University of HoustonTerminated
-
Centre Hospitalier Régional d'OrléansRecruiting